OBIO · Insider Trading
Orchestra BioMed Holdings, Inc. Ordinary Shares
Every open-market purchase and sale reported by OBIO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Darren Sherman | See Remarks | Sell | −15,000 | −$95.40K |
| 2026-09-11 | David P Hochman | See Remarks | F | −6,566 | −$38.15K |
| 2026-09-08 | David P Hochman | See Remarks | Buy | +10,000 | +$47.90K |
| 2026-09-02 | Darren Sherman | See Remarks | Sell | −15,000 | −$74.10K |
| 2026-08-28 | Joshua Aiello | Principal Accounting Officer | F | −203 | −$1.07K |
| 2026-08-28 | Andrew Lawrence Taylor | Chief Financial Officer | F | −3,076 | −$16.18K |
| 2026-08-28 | Darren Sherman | See Remarks | MIXED | −2,925 | −$15.25K |
| 2026-08-14 | John Prosper Mack | Director | F | −4,885 | −$21.59K |
| 2026-08-14 | Chris Cleary | Director | F | −4,238 | −$18.73K |
| 2026-08-14 | Eric S Fain | Director | F | −5,145 | −$22.74K |
| 2026-08-14 | David Pacitti | Director | F | −3,761 | −$16.62K |
| 2026-08-04 | Darren Sherman | See Remarks | Sell | −15,000 | −$61.35K |
| 2026-07-02 | Darren Sherman | See Remarks | Sell | −15,000 | −$64.05K |
| 2026-06-25 | Jason Aryeh | Director | A | +42,553 deriv. | — |
| 2026-06-25 | John Prosper Mack | Director | MIXED | +31,143 | — |
| 2026-06-25 | Eric S Fain | Director | MIXED | +13,066 | — |
| 2026-06-25 | Pamela Ann Connealy | Director | A | +17,327 | — |
| 2026-06-25 | David Pacitti | Director | MIXED | +13,543 | — |
| 2026-06-25 | Chris Cleary | Director | F | −3,510 | — |
| 2026-06-12 | David P Hochman | See Remarks | F | −6,566 | −$26.40K |
| 2026-06-12 | Andrew Lawrence Taylor | Chief Financial Officer | F | −36,352 | −$146.14K |
| 2026-06-02 | Darren Sherman | See Remarks | Sell | −15,000 | −$58.05K |
| 2026-06-02 | David P Hochman | See Remarks | Buy | +5,000 | +$19.15K |
| 2026-05-29 | Darren Sherman | See Remarks | F | −4,925 | −$19.60K |
| 2026-05-29 | Andrew Lawrence Taylor | Chief Financial Officer | F | −3,076 | −$12.24K |
| 2026-05-20 | Jason Aryeh | Director | Buy | +665 | +$2.49K |
| 2026-05-19 | Jason Aryeh | Director | Buy | +8,971 | +$34.99K |
| 2026-05-19 | David P Hochman | See Remarks | Buy | +5,000 | +$18.85K |
| 2026-05-18 | Eric S Fain | Director | Buy | +20,000 | +$82.60K |
| 2026-04-29 | Roderick Wong | 10%+ Owner | MIXED | +2,500,000 | −$14 |
| 2026-03-27 | Darren Sherman | See Remarks | F | −33,317 | −$152.26K |
| 2026-03-27 | Joshua Aiello | Principal Accounting Officer | F | −241 | −$1.10K |
| 2026-03-27 | David P Hochman | See Remarks | F | −32,438 | −$148.24K |
| 2026-03-16 | David P Hochman | See Remarks | Buy | +10,000 | +$42.90K |
| 2026-02-13 | Darren Sherman | See Remarks | A | +397,000 | — |
| 2026-02-13 | Andrew Lawrence Taylor | Chief Financial Officer | A | +181,000 | — |
| 2026-02-13 | David P Hochman | See Remarks | A | +504,000 | — |
| 2026-02-13 | Joshua Aiello | Principal Accounting Officer | A | +70,000 deriv. | — |
| 2026-02-06 | Darren Sherman | See Remarks | A | +34,974 deriv. | — |
| 2026-02-06 | Chris Cleary | Director | F | −676 | −$2.51K |
| 2026-01-02 | Andrew Lawrence Taylor | Chief Financial Officer | F | −3,452 | −$14.88K |
| 2026-01-02 | Joshua Aiello | Principal Accounting Officer | F | −241 | −$1.04K |
| 2026-01-02 | Darren Sherman | See Remarks | F | −5,588 | −$24.08K |
| 2025-12-12 | Andrew Lawrence Taylor | Chief Financial Officer | F | −8,670 | −$40.49K |
| 2025-12-12 | David P Hochman | See Remarks | F | −43,638 | −$203.79K |
| 2025-11-26 | Darren Sherman | See Remarks | F | −40,340 | −$215.82K |
| 2025-11-26 | Andrew Lawrence Taylor | Chief Financial Officer | F | −3,071 | −$16.43K |
| 2025-11-17 | David P Hochman | See Remarks | Buy | +5,000 | +$20.35K |
| 2025-11-14 | David P Hochman | See Remarks | F | −6,566 | −$27.45K |
| 2025-09-19 | David P Hochman | See Remarks | F | −43,638 | −$107.35K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Roderick Wong | 10%+ Owner | 9,556,063 | $53.04M |
| RTW INVESTMENTS, LP | 10%+ Owner | 8,306,063 | $46.10M |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10%+ Owner | 5,292,556 | $29.37M |
| Darren Sherman | See Remarks | 1,121,402 | $6.22M |
| David P Hochman | See Remarks | 1,070,603 | $5.94M |
| Andrew Lawrence Taylor | Chief Financial Officer | 589,989 | $3.27M |
| Jason Aryeh | Director | 118,118 | $655.55K |
| Eric S Fain | Director | 107,130 | $594.57K |
| John Prosper Mack | Director | 66,544 | $369.32K |
| Pamela Ann Connealy | Director | 66,038 | $366.51K |
| David Pacitti | Director | 54,750 | $303.86K |
| Chris Cleary | Director | 29,153 | $161.80K |
| Joshua Aiello | Principal Accounting Officer | 18,441 | $102.35K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OBIO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.